Author

M Krammer

Observed institution: GlaxoSmithKline (Germany)

OpenAlex ID: A5115629256

Transfusion-related costs in anemic myelofibrosis patients treated with JAK inhibitors in Germany

2026 · M Krammer, C Iwamoto, et al. · European Journal of Public Health

EE627 Hospitalization Costs and Disease Burden ofB. Pertussis in Germany: A Retrospective Analysis of Nationwide Inpatient Data Collected From 2019 to 2023

2024 · M Krammer, J Reinhardt, et al. · Value in Health

EPH36 Evaluation of the Impact of Herpes Zoster Vaccination in 18 to 49 Years Old German Patients With Immunosuppression on Public Health Measures

2024 · M Waize, M Dichtl, et al. · Value in Health

Works count: 3

Citation count:

H-index:

I10-index: